This patent covers the use of a specialized cell population obtained from xenogeneic sources for the stimulation of recovery of various neurological disorders. Specifically, the patent covers pig lateral ganglionic eminence cells that are treated so as to not elicit immune rejection.
View this patent on the USPTO website.
You must be signed-in to add your comments.
Sign-in now or Join the StemCellPatents.com Community for free.